[{"name":"Debate Contra: Patients should be selected based on predictive biomarkers","mode":"","is_cme":false,"info":{"presentation":"Debate Contra: Patients should be selected based on predictive biomarkers","session":"Session 2: Are all fit patients candidates for 1st-line treatment with Immune Check Point Inhibitors?","presenter":"D. Planchard","photo":null},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/lung2019\/5\/v\/5_1c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/lung2019\/5\/v\/5_1c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/lung2019\/5\/v\/5_1c.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"aL240602VK"}